Medicalgorithmics strengthens Shareholder structure. Investors acquire shares worth nearly PLN 70 million
Medicalgorithmics S.A., a global innovator in ECG and cardiac imaging diagnostics, has seen its shares acquired by leading Polish Open Pension Funds (OFE), Investment Fund Managers (TFI), and family foundations. Biofund Capital Management LLC, the main shareholder of Medicalgorithmics, has once again expanded the company’s institutional shareholder base by selling 2.1 million shares valued at nearly PLN 70 million. The transaction comes in response to high investor demand following the Company’s announcement of breakthrough estimated results for Q4 2025.
Simultaneously, Biofund has submitted a binding offer to the Company, including a 12-month lock-up agreement and a significant reduction in financing costs for the loan granted in 2024. The fund has also committed to negotiations regarding the conversion of the loan (including interest) into Company shares.